Live Breaking News & Updates on Sherbrooke Park Advisers

Stay updated with breaking news from Sherbrooke park advisers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fund 1 Investments LLC Buys 852,330 Shares of Vera Bradley, Inc. (NASDAQ:VRA)

Fund 1 Investments LLC raised its stake in shares of Vera Bradley, Inc. (NASDAQ:VRA – Free Report) by 93.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,762,471 shares of the textile maker’s stock after buying an additional […] ....

Pura Vida , Vera Bradley , Tower Research Capital , Vera Bradley Inc , Sherbrooke Park Advisers , Exchange Commission , Harbor Capital Advisors Inc , Vera Bradley Company Profile , Free Report , Capital Advisors , Research Capital , Park Advisers , Clear Street Markets , Get Free Report , Vera Bradley Direct , Vera Bradley Indirect , Visit Holdingschannel , Vera Bradley Daily ,

Olo Inc. (NYSE:OLO) CEO Sells $45,900.60 in Stock

Olo Inc. (NYSE:OLO – Get Free Report) CEO Noah H. Glass sold 10,155 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $4.52, for a total transaction of $45,900.60. Following the sale, the chief executive officer now directly owns 322,816 shares in the […] ....

United States , Piper Sandler , Victory Capital Management Inc , Olo Inc , Benjaminf Edwards Company Inc , Sherbrooke Park Advisers , Rockport Wealth , Company Profile , Securities Exchange Commission , Get Free Report , Exchange Commission , Park Advisers , Capital Management , Solo Pay ,

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Brucei Sachs , Reshma Kewalramani , Piper Sandler , News Ratings For Vertex Pharmaceuticals Daily , Insider Transactions At Vertex Pharmaceuticals , Canaccord Genuity Group , Securities Exchange Commission , Vertex Pharmaceuticals Profile , Wolfe Research , Bellevue Group , Telos Capital Management Inc , Quarter For Vertex Pharmaceuticals , Investment Management , Cantor Fitzgerald , Exchange Commission , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals , Sherbrooke Park Advisers , Vertex Pharmaceuticals Stock , Morgan Stanley , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Director Bruce ,

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Reshma Kewalramani , Brucei Sachs , Piper Sandler , Canaccord Genuity Group , Telos Capital Management Inc , Cantor Fitzgerald , Quarter For Vertex Pharmaceuticals , Sherbrooke Park Advisers , Vertex Pharmaceuticals Stock , Insider Transactions At Vertex Pharmaceuticals , Vertex Pharmaceuticals , Securities Exchange Commission , Exchange Commission , News Ratings For Vertex Pharmaceuticals Daily , Investment Management , Vertex Pharmaceuticals Incorporated , Bellevue Group , Morgan Stanley , Wolfe Research , Vertex Pharmaceuticals Profile , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Director Bruce ,

Bellevue Group AG Has $95.75 Million Holdings in MacroGenics, Inc. (NASDAQ:MGNX)

Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […] ....

United States , Jeffrey Stuart Peters , Stifel Nicolaus , Macrogenics Inc , Sherbrooke Park Advisers , Bellevue Group , China Universal Asset Management Co , Holdings Channel , Jump Financial , Free Report , Universal Asset Management , Park Advisers , Stuart Peters , Get Free Report , Visit Holdingschannel , Macrogenics Daily ,